Hedi Gharsallah

Dr. Hedi Gharsallah

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
ZHZied Hajjej
Zied Hajjej
MNMourad Nasri
Mourad Nasri
WSWalid Sellami
Walid Sellami
HGHedi Gharsallah
Hedi Gharsallah
ILIheb Labben
Iheb Labben
MFMustapha Ferjani
Mustapha Ferjani

17 June 2022 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
NSNejla Stambouli
Nejla Stambouli
Adel DrissAdel Driss
Adel Driss
FGFaten Gargouri
Faten Gargouri
KBKhadija Bahrini
Khadija Bahrini
BABilel Arfaoui
Bilel Arfaoui
HGHedi Gharsallah
Hedi Gharsallah
This study aims to assess the efficacy of a combination treatment of doxycycline and zinc in the primary prevention of COVID-19 infection in Tunisian health care workers compared with two control groups. We conducted a prospective, randomized, double-blind clinical trial over 5 months to determine the efficacy of a preventive combination treatment dose of doxycycline (100 mg/day) and zinc (15 mg/day), compared with a single-dose treatment with doxycycline versus placebo. The effectiveness of preventive treatment was measured by the significant decline in the number of cases of COVID-19 infection and/or a decrease in the viral load as determined by SARS-CoV-2 cycle threshold value using reverse transcription polymerase chain reaction tests. We detected a significant decrease of SARS-CoV-2 infection in the group that received both doxycycline and zinc compared with other participants. We also demonstrated that COVID-19 infection was neither associated with diabetes (P = 0.51) nor associated with hypertension (P = 0.99), asthma (P = 0.52), and chronic obstructive pulmonary disease (P = 0.27). Our findings indicated that preventive therapy reduced the risk of SARS-CoV-2. These results suggest that the combination of doxycycline and zinc has a protective effect in patients with SARS-CoV-2 infection.
1

1 February 2020 in Journal Français d'Ophtalmologie
Verified
Journal Article
Closed access
AMA. Maalej
A. Maalej
AKA. Khallouli
A. Khallouli
RCR. Choura
R. Choura
RSR. Ben Sassi
R. Ben Sassi
RRR. Rannen
R. Rannen
HGHedi Gharsallah
Hedi Gharsallah

1 January 2016 in IDCases
Verified
Journal Article
Open access
ZHZied Hajjej
Zied Hajjej
HGHedi Gharsallah
Hedi Gharsallah
HNHabiba Naija
Habiba Naija
IBIlhem Boutiba
Ilhem Boutiba
ILIheb Labbene
Iheb Labbene
MFMustapha Ferjani
Mustapha Ferjani
We describe a case of 58-year-old man with septic shock due to Carbapenem-resistant Klebsiella pneumoniae (CR-Kp) bloodstream infections (BSI) who was successfully treated with a high dose association of amikacin and imipenem combined with continuous venovenous hemodiafiltration (CVVHDF). A Klebsiella pneumoniae (Kp) was isolated from the catheter culture and from two blood samples, drawn from the catheter before removal and from a peripheral vein. The Kp was intermediate to Amikacin (MIC = 16 μg/ml) and was resistant to all other antibiotics including Imipenem (MIC = 4 μg/ml), Colistin (MIC = 16 μg/ml) and Tigecycline (MIC = 4 μg/ml) according to the Clinical and Laboratory Standards Institute (CLSI) published in 2011. PCR amplification and sequencing verified the presence of blaOXA-48, blaVIM-2, blaCMY-2 and blaSHV-1 genes. Amikacin was given at a dose of 30 mg/kg (2.5 g) in a 30 min infusion and the dose of imipenem was increased to 1 g every 6 h despite patient's altered renal function (Creatinine Clearance = 25 ml/min). To avoid amikacin nephrotoxicity and to allow the use of high doses of imipenem, continuous venovenous hemodiafiltration (CVVHDF) (blood flow, 200 ml/h; dialysate, 1000 ml/h; ultrafiltrate, 2000 ml/h) was initiated 1 h after the start of the amikacin infusion and continued thereafter. The patient improved hemodynamically and norepinephrine was stopped five days after antibiotherapy adaptation.

1 March 2020 in Medical Mycology Case Reports
Verified
Journal Article
Open access
LMLatifa MTIBAA
Latifa MTIBAA
CHChiraz Halwani
Chiraz Halwani
MTMakram Tbini
Makram Tbini
SBSiwar Boufares
Siwar Boufares
HSHana Souid
Hana Souid
BJBoutheina Jemli
Boutheina Jemli
Mucormycosis is a rapidly progressing and lethal infection caused by fungi of the order mucorales. The disease occurs mostly in patients with uncontrolled diabetes or other predisposing systemic conditions. We report a case of rhinofacial mucormycosis in a 39-year-old diabetic patient. The diagnosis was established by clinical examination, imaging, and confirmed by mycological examination. Rhizopus arrhizus was isolated. He was successfully treated with amphotericin B, surgical resection, diabetes control and hyperbaric oxygen therapy.

23 April 2023 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
KBkhadija bahrini
khadija bahrini
NSNejla Stambouli
Nejla Stambouli
MAMouna Ben Azaiez
Mouna Ben Azaiez
ARAicha Rebai
Aicha Rebai
FAFerid Abid
Ferid Abid
MFMustapha Ferjani
Mustapha Ferjani
Background. Immune response plays a crucial role in virus clearance during COVID-19 infection and underpins vaccine efficacy. Herein, we aimed to assess the immune response during COVID-19 infection and following SARS-CoV-2 vaccination. Methods. In this retrospective study, 94 confirmed COVID-19 patients admitted to the intensive care unit were categorized into unvaccinated patients (n = 50), including 33 deceased and 17 discharged patients, and vaccinated group (n = 44) with 26 deceased and 18 discharged patients. Records of patients with severe COVID-19 admitted to the ICU between March, 2021 and March, 2022 were gathered and analyzed. Result. The assessment of immune cell counts revealed a large rise of neutrophils associated to decrease number of lymphocytes in patients with COVID-19 infection. In dead patients, we detected a significant correlation between neutrophils and inflammatory parameters such as IL-6 and CRP. Moreover, analysis of immune cell count following vaccination did not reveal any significant difference. However, the most substantial result, herein, detected is the decrease level of IL-6 in vaccinated patients as compared to unvaccinated. The reduce level of IL-6 following vaccination is observed in discharged patients as compared to deceased. Regarding the level of mortality after vaccination, we showed that all patients who received the first dose were died (46.1%, n = 12) as compared to those who have received two doses (34.6%, n = 9) and the third dose of vaccine (19.23%, n = 3) ( ). Strikingly, studying the inflammatory parameters after each vaccine dose, we revealed a significant decrease of IL-6 level after the booster dose (third dose), especially in vaccinated discharged patients. Conclusions. Neutrophils combined with IL-6 and CRP can be very useful markers to predict disease severity in patients admitted to ICU. The decrease level of IL-6 in vaccinated group pointed out the impact of vaccination to prevent inflammatory cytokine release.